IN THE NEWS: EGFR Mutation Testing for Non-Small Cell Lung Cancer

Patient Power

Dipesh Uprety, M.D., medical oncologist and member of the Thoracic Oncology and Phase I Clinical Trials Multidisciplinary Teams, explained EGFR mutation testing. This procedure examines DNA sequences of non-small cell lung cancer tumor cells for mutations in the epidermal growth factor receptor (EGFR) gene. Dr. Uprety described the types of treatments that can be used if the mutation is found.

Read the article here.

Dipesh Uprety, M.D.